The evolving role of specific estrogen receptor modulators (SERMs)
- 31 August 1999
- journal article
- review article
- Published by Elsevier BV in Surgical Oncology
- Vol. 8 (2), 103-123
- https://doi.org/10.1016/s0960-7404(99)00047-x
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Influence of toremifene on the endocrine regulation in breast cancer patientsEuropean Journal Of Cancer, 1994
- Selective reversal of vinblastine resistance in multidrug-resistant cell lines by tamoxifen, toremifene and their metabolitesEuropean Journal Of Cancer, 1993
- Phase II clinical study of high-dose toremifene in patients with advanced breast cancerJournal of Steroid Biochemistry, 1990
- Treatment of advanced breast cancer with 20 mg toremifene, a phase II study. Preliminary communicationJournal of Steroid Biochemistry, 1990
- Effect of toremifene on clinical chemistry, hematology and hormone levels at different doses in healthy postmenopausal volunteers: Phase I studyJournal of Steroid Biochemistry, 1990
- Phase II clinical study of toremifene in patients with metastatic breast cancer. Preliminary communicationJournal of Steroid Biochemistry, 1990
- Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: A model to study the tumoristatic action of tamoxifenJournal of Steroid Biochemistry, 1988
- Novel antioestrogens without partial agonist activityJournal of Steroid Biochemistry, 1988
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896